While standard flower and raw pre-rolls continue to face market-wide price decay, infused pre-rolls are breaking the trend—holding their pricing power and expanding retail margins across key Eastern and Midwestern markets.
The Numbers: Standard vs. Infused Pre-Roll Pricing
Tracking 12 months of retail menu data reveals a clear divergence between traditional pre-rolls and concentrate-infused alternatives:
Standard Pre-Rolls Slide: Over the course of the year, standard pre-roll prices dropped 4.25%, declining from an average of $21.88 in July to $20.95 by June.
Infused Pre-Rolls Gain Ground: Infused pre-rolls defied the broader market price compression, increasing by 2.51% over the same period—climbing from $29.46 in July to $30.20 in June.
Expanding Margin Premium: The price gap between the two product types expanded substantially. In July, infused pre-rolls commanded a 34.6% ($7.58) premium over standard joints. By June, that premium grew to 44.2% ($9.25) per unit.
Why Infused Pre-Rolls Are Defying Price Decay
Perceived Value & Potency: Consumers viewing high-THC infused SKUs as a higher-potency, longer-lasting experience are far less sensitive to minor price changes compared to standard flower buyers.
Biomass & Concentrate Synergy: Cultivators and processors can utilize lower-tier flower or trim by combining it with terpene-rich concentrates, converting lower-margin raw materials into high-margin finished products.
Retail Shelf Allocation: Dispensaries are prioritizing infused pre-rolls because they deliver higher dollar-per-transaction averages at the register without taking up extra shelf space.
For brands and processors evaluating product roadmaps, shifting biomass toward infused pre-roll lines offers one of the most immediate, reliable hedges against ongoing wholesale flower compression.
Sign up for a free trial today or book a personalized demo to start receiving real-time, actionable market signals for you and your entire team.
